Universal-Beteiligungs- und Servicegesellschaft
TARS icon

Universal-Beteiligungs- und Servicegesellschaft’s Tarsus Pharmaceuticals TARS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800K Sell
12,718
-77,945
-86% -$4.98M ﹤0.01% 1649
2026
Q1 		$6.36M Sell
90,663
-19,194
-17% -$1.34M 0.01% 775
2025
Q4 		$9M Buy
109,857
+18,267
+20% +$1.36M 0.01% 649
2025
Q3 		$5.44M Buy
91,590
+39,838
+77% +$1.96M 0.01% 834
2025
Q2 		$2.1M Buy
51,752
+16,359
+46% +$736K ﹤0.01% 1228
2025
Q1 		$1.82M Buy
+35,393
New +$1.75M ﹤0.01% 1245

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's TARS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Tarsus Pharmaceuticals (TARS) stake by 86% in Q2 2026, selling an estimated $4.98M and leaving 12,718 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in TARS in Q1 2025 and has held it in 6 quarters since. The position peaked at $9M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 12,718 shares of Tarsus Pharmaceuticals worth $800K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 77,945 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $4.98M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1649 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Tarsus Pharmaceuticals position peaked at $9M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.